To explore the role of CCL2, we blocked the CCL2 gene by RNA interference or adenovirus injection and found that astrocytic CCL2 inhibition can effectively reduce NMO-IgG damage or mitigate the pathological lesions of NMO (Figures 4; 5). Here, CCL2 is linked to neuromyelitis optica.